Skip to content

BIIB · Biogen Inc.

Healthcare · −1.1% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 1 day, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive BIIB chart (by TradingView) loads here.

Our take

9 rules fired on BIIB

In short: none of these rules has solid or some evidence yet, so they show no clear lean on BIIB.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 9 rules
The 0–100 score for BIIB, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on BIIB, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of BIIB. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded

Congress purchases

Within earlier range

This count falls within the range of the 12 earlier comparable periods in this view.

Latest 28 days
0
Earlier median
0
Earlier range
0–2
Distinct filers per 28 daysScale: 0–2
Oct 20, 2025Oct 18, 2026
Earlier periodsLatest 28 daysEarlier median 0

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: May 1, 2014. Newest disclosure across this feed: Oct 15, 2026.

Earlier periods in the comparison: 12. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 20260Partial; excluded
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Insider sales · Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 20261Partial; excluded
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Congress purchases · Within earlier range

This count falls within the range of the 12 earlier comparable periods in this view. Earlier median: 0; range: 0–2.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20261Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20261Within stored history
Jun 29, 2026–Jul 26, 20262Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Congress sales · Sparse history

Only 2 of 12 earlier periods had activity. That is too little recurring activity to label this count unusual. Earlier median: 0; range: 0–1.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 20250Within stored history
Nov 17, 2025–Dec 14, 20250Within stored history
Dec 15, 2025–Jan 11, 20260Within stored history
Jan 12, 2026–Feb 8, 20260Within stored history
Feb 9, 2026–Mar 8, 20260Within stored history
Mar 9, 2026–Apr 5, 20260Within stored history
Apr 6, 2026–May 3, 20260Within stored history
May 4, 2026–May 31, 20260Within stored history
Jun 1, 2026–Jun 28, 20260Within stored history
Jun 29, 2026–Jul 26, 20261Within stored history
Jul 27, 2026–Aug 23, 20260Within stored history
Aug 24, 2026–Sep 20, 20261Within stored history
Sep 21, 2026–Oct 18, 2026Latest period1Within stored history
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Public officials

FDA & trials

Owners & lobbying

Public officials · Oct 2026

  1. Disclosed
    Maria Elvira Salazar · Sale (partial)

    Transaction dated Sep 24, 2026

All 27 records in this snapshot
  1. Disclosed
    Maria Elvira Salazar · Sale (partial)

    Transaction dated Sep 24, 2026

  2. Record date
  3. Record date
    FDA approval: Byooviz ↗

    BLA · supplement

  4. Disclosed
    Kevin Hern · Sale

    Transaction dated Aug 18, 2026

  5. Record date
  6. Disclosed
    Lloyd Minor · Sale

    Transaction dated Aug 4, 2026

  7. Disclosed
    Lloyd Minor · Sale

    Transaction dated Aug 3, 2026

  8. Filed
  9. Filed
  10. Filed
  11. Record date
  12. Filed
  13. Disclosed
    Alan Armstrong · Purchase

    Transaction dated Mar 27, 2026

  14. Record date
    Lobbying for Biogen ↗

    $1.1M · by Biogen

  15. Record date
    Lobbying for Biogen, Inc. ↗

    $50K · by Federal Street Strategies, LLC

  16. Record date
    Lobbying for Biogen, Inc. ↗

    $50K · by Todd Strategy Group

  17. Record date
    Lobbying for Biogen, Inc. ↗

    $60K · by Dla Piper LLP (US)

  18. Disclosed
    Gilbert Ray Cisneros Jr · Purchase

    Transaction dated Jun 5, 2026

  19. Disclosed
    Maria Elvira Salazar · Sale

    Transaction dated Jun 2, 2026

  20. Filed
  21. Filed
  22. Filed
  23. Record date
  24. Disclosed
    Maria Elvira Salazar · Purchase

    Transaction dated May 11, 2026

  25. Disclosed
    Maria Elvira Salazar · Purchase

    Transaction dated May 12, 2026

  26. Disclosed
    Maria Elvira Salazar · Purchase

    Transaction dated May 11, 2026

  27. Record date

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

1 member bought, 2 sold · 3 Rep

  1. ▼ SELLMaria Elvira Salazar Rep · House · FLBIIB Biogen Inc.$1K–$15Kdisclosed Oct 1 · filed 7 days after the trade
  2. ▼ SELLKevin Hern Rep · House · OKBIIB Biogen Inc.$1K–$15Kdisclosed Aug 27 · filed 9 days after the trade
  3. ▲ BUYAlan Armstrong Rep · Senate · OKBIIB Biogen Inc.$1K–$15Kdisclosed Jul 21 · filed 116 days after the trade · late 1 rule fired
See every Congress trade on BIIB →

Company insiders

0 buys · 1 sell (2 filed lots) · $240K sold

  1. ▼ SELLLloyd Minor DirectorBIIB Biogen Inc.$119Kdisclosed Aug 5 · filed 1 day after the trade
  2. ▼ SELLLloyd Minor DirectorBIIB Biogen Inc.$121Kdisclosed Aug 5 · filed 2 days after the trade
See every insider trade on BIIB →

Filings & events

Company filings (8-K) 65

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.0215
  • Shareholder vote results · item 5.075
  • Signed a major agreement · item 1.015
  • Other events · item 8.014
  • Took on new debt · item 2.033
  • Directors or officers joined, left or got new pay · item 5.023

Filing red flags 19

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Lobbying 79

Lobbying reports filed with the Senate for the company.

$20.3M across 79 reports

Issues named in the most reports

  • Health Issues 79
  • Medicare/Medicaid 68
  • Taxation/Internal Revenue Code 31
  • Pharmacy 25
  • Trade (domestic/foreign) 23

Planned insider sales (Form 144) 15

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

2 in the last 90 days · 15 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 3

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 0 filings
  • 13G, just holds: 3 filings

Filed by Vanguard Capital Management LLC · Fmr LLC · State Street Corp

Biggest named funds (13F)

The largest BIIB holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on BIIB

  1. ▼ SELLMaria Elvira Salazar Rep · House · FLBIIB Biogen Inc.$1K–$15Kdisclosed Oct 1 · filed 7 days after the trade
  2. ▼ SELLKevin Hern Rep · House · OKBIIB Biogen Inc.$1K–$15Kdisclosed Aug 27 · filed 9 days after the trade
  3. ▼ SELLLloyd Minor DirectorBIIB Biogen Inc.$119Kdisclosed Aug 5 · filed 1 day after the trade
  4. ▼ SELLLloyd Minor DirectorBIIB Biogen Inc.$121Kdisclosed Aug 5 · filed 2 days after the trade
  5. ▲ BUYAlan Armstrong Rep · Senate · OKBIIB Biogen Inc.$1K–$15Kdisclosed Jul 21 · filed 116 days after the trade · late 1 rule fired
  6. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CABIIB Biogen Inc.$1K–$15Kdisclosed Jul 2 · filed 27 days after the trade
  7. ▼ SELLMaria Elvira Salazar Rep · House · FLBIIB Biogen Inc.$15K–$50Kdisclosed Jul 1 · filed 29 days after the trade
  8. ▲ BUYMaria Elvira Salazar Rep · House · FLBIIB Biogen Inc.$50K–$100Kdisclosed Jun 1 · filed 21 days after the trade
  9. ▲ BUYMaria Elvira Salazar Rep · House · FLBIIB Biogen Inc.$1K–$15Kdisclosed Jun 1 · filed 20 days after the trade
  10. ▲ BUYMaria Elvira Salazar Rep · House · FLBIIB Biogen Inc.$1K–$15Kdisclosed Jun 1 · filed 21 days after the trade
  11. ▲ BUYGilbert Ray Cisneros Jr Dem · House · CABIIB Biogen Inc.$1K–$15Kdisclosed Feb 11 · filed 12 days after the trade
  12. ▲ BUYRobert P. Bresnahan Jr Rep · House · PABIIB Biogen Inc.$1K–$15Kdisclosed May 15, 2025 · filed the same day 1 rule fired
  13. ▼ SELLRobert P. Bresnahan Jr Rep · House · PABIIB Biogen Inc.$1K–$15Kdisclosed Apr 8, 2025 · filed the same day
  14. ▲ BUYRobert P. Bresnahan Jr Rep · House · PABIIB Biogen Inc.$1K–$15Kdisclosed Feb 25, 2025 · filed the same day 1 rule fired
  15. ▼ SELLSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$1K–$15Kdisclosed Apr 26, 2019 · filed 35 days after the trade
  16. ▼ SELLSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$1K–$15Kdisclosed Feb 12, 2018 · filed 35 days after the trade
  17. ▼ SELLSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$1K–$15Kdisclosed Jan 27, 2017 · filed 35 days after the trade
  18. ▼ SELLSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$15K–$50Kdisclosed Jan 17, 2017 · filed 35 days after the trade
  19. ▼ SELLJames M. Inhofe Rep · Senate · OKBIIB Biogen Inc.$50K–$100Kdisclosed Aug 25, 2016 · filed 35 days after the trade
  20. ▲ BUYSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$1K–$15Kdisclosed Oct 2, 2015 · filed 35 days after the trade
  21. ▲ BUYSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$1K–$15Kdisclosed Sep 14, 2015 · filed 35 days after the trade
  22. ▲ BUYSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$1K–$15Kdisclosed Sep 8, 2015 · filed 35 days after the trade
  23. ▲ BUYSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$1K–$15Kdisclosed Aug 14, 2015 · filed 35 days after the trade
  24. ▲ BUYJames M. Inhofe Rep · Senate · OKBIIB Biogen Inc.$15K–$50Kdisclosed Aug 13, 2015 · filed 35 days after the trade
  25. ▲ BUYSheldon Whitehouse Dem · Senate · RIBIIB Biogen Inc.$15K–$50Kdisclosed Jun 11, 2015 · filed 35 days after the trade
See all 28 trades on BIIB →
People & votes

Which members of Congress traded BIIB, sponsored bills that touch it and voted on them — opens here.